NEOPLASMS
Clinical trials for NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS trials appear
Sign up with your email to follow new studies for NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver tumors targeted directly: old pump, new drug
Disease control Not yet recruitingThis trial tests whether a drug called carfilzomib, given directly to the liver through an implanted pump, is safe for people whose colon, adrenal, or bile duct cancer has spread to the liver and persists after prior pump therapy. Participants receive weekly infusions of the drug…
Matched conditions: NEOPLASMS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New vaccine combo aims to halt prostate cancer growth without surgery
Disease control Not yet recruitingThis phase 2 trial tests a combination of a vaccine (TriAdeno) and an immune-boosting drug (N-803) in 52 men with early-stage, low- or medium-risk prostate cancer who are currently on active surveillance. The vaccine targets three proteins found in prostate cancer cells, while N-…
Matched conditions: NEOPLASMS
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Inhaled mRNA therapy takes on solid tumors in first human trial
Disease control Not yet recruitingThis early-phase study tests an inhaled mRNA immunotherapy for adults with advanced lung cancer or solid tumors that have spread to the lungs. The treatment is given as a dry powder through an inhaler. The main goal is to check safety and find the best dose, with 60 participants …
Matched conditions: NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for advanced HER2 cancers? drug trial launches
Disease control Not yet recruitingThis early-phase study tests a drug called zanidatamab in 10 adults with advanced HER2-positive solid tumors (like endometrial, bladder, or pancreatic cancer) that have worsened after at least one prior treatment. Participants receive the drug by IV every two weeks. The main goal…
Matched conditions: NEOPLASMS
Phase: PHASE2 • Sponsor: Haihua Yuan • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can spirulina and fish oil tame immunotherapy lung side effects?
Disease control Not yet recruitingThis study looks at whether adding a mix of nutritional supplements (spirulina, bifidobacterium, fish oil, grape seed, blueberry, and ganoderma spore oil) to standard steroid treatment can help people with severe lung inflammation caused by cancer immunotherapy. About 60 adults w…
Matched conditions: NEOPLASMS
Phase: NA • Sponsor: Guangzhou Institute of Respiratory Disease • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New imaging agent could spot hidden cancers
Diagnosis Not yet recruitingThis study tests a new radioactive imaging agent called 68Ga-SFB6-ZN01, which is designed to attach to a protein found on many cancer cells. 98 adults with confirmed or suspected cancer will receive a single injection of the agent and then have a PET/CT scan. The goal is to see i…
Matched conditions: NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Zhongnan Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
A virtual Walk-Through of radiotherapy may calm cancer Patients' nerves
Symptom relief Not yet recruitingMany cancer patients feel anxious before radiotherapy, partly due to unfamiliar equipment and procedures. This trial tests whether adding a simulation-based education session — a virtual preview of the treatment environment — before standard education can reduce that anxiety and …
Matched conditions: NEOPLASMS
Phase: NA • Sponsor: University Medical Center Goettingen • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a simple text message transform cancer care?
Symptom relief Not yet recruitingThis trial tests whether regular text-message check-ins can help advanced cancer patients get palliative care support earlier. Patients receive a text every two weeks asking them to rate their symptoms online. If any symptoms are concerning, a coordinator calls to assess and mana…
Matched conditions: NEOPLASMS
Phase: NA • Sponsor: National Cancer Centre, Singapore • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
New web tool hopes to ease cancer Survivors' emotional struggles
Symptom relief Not yet recruitingThis pilot study tests an online program called Finding My Way-UK for people who finished curative cancer treatment in the past year. The program includes six self-guided modules on coping, emotions, and body image. Researchers will check if it's easy to use and if it helps with …
Matched conditions: NEOPLASMS
Phase: NA • Sponsor: Edge Hill University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Emotional support may ease distress during cancer genetic testing
Knowledge-focused Not yet recruitingThis study looks at how people feel emotionally when they go through cancer genetic testing, and whether talking to a psychologist helps. It follows 220 adults who are having their first genetic counseling session. Some choose to use the psychological support offered, while other…
Matched conditions: NEOPLASMS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
AI could outshine standard tumor measurements to predict survival
Knowledge-focused Not yet recruitingThis study is developing an artificial intelligence system that measures changes in total tumor volume from CT or MRI scans to see if it can predict survival better than the current standard method, which measures just a few tumors. Researchers will analyze data from about 6,000 …
Matched conditions: NEOPLASMS
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
New study aims to predict immunotherapy success in cancer patients
Knowledge-focused Not yet recruitingThis study will collect data from 500 cancer patients who are about to start immunotherapy. Researchers want to build a tool that can predict survival outcomes based on factors like combination treatments. The goal is to help doctors and patients make more informed decisions abou…
Matched conditions: NEOPLASMS
Sponsor: Sichuan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
New camera could spare skin cancer patients from unnecessary biopsies
Knowledge-focused Not yet recruitingThis study tests a non-invasive imaging technique called LC-OCT for diagnosing basal cell carcinoma, the most common skin cancer. Researchers will review medical records of about 300 patients to see if LC-OCT can accurately detect cancer and guide treatment without needing a biop…
Matched conditions: NEOPLASMS
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Frozen hope: new study tracks fertility in young cancer survivors
Knowledge-focused Not yet recruitingThis study follows 100 young cancer patients (ages 0-18) who freeze their ovarian tissue before treatment. Researchers want to see how safe the procedure is and how many go on to have a baby after transplanting the tissue back. The goal is to learn if this method effectively pres…
Matched conditions: NEOPLASMS
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Where you live may affect your cancer care: new study investigates
Knowledge-focused Not yet recruitingThis study will look at where 300 cancer patients at Delafontaine Hospital live and how long it takes them to get to appointments. By mapping anonymized addresses, researchers hope to understand how distance, transportation, and social factors create inequalities in access to car…
Matched conditions: NEOPLASMS
Sponsor: Centre Hospitalier de Saint-Denis • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC